[ad_1]
This is a copy of the November 18th edition of our weekly newsletter, which we have been publishing since October 2015.
Friends,
One of the great stories of 2018 was the launch of the welcome mat for licensed Canadian producers, NASDAQ and the NYSE, with Cronos Group and Tilray listing on the NASDAQ and Aphria companies' inventory, Aurora Cannabis and Canopy Growth of the Big Board. With federal legality in Canada, these big exchanges have no reason to reject businesses. As we have already said, we expect to see more Canadian record companies take the initiative, and we suggest that Aleafia, CannTrust, HEXO Corp and Organigram be among the groups likely to expand this list. .
We believe that 2019 could be a pivotal year for US companies wishing to trade on a major market, which, if correct, could significantly expand the investor base. Currently, Cannabis REIT Innovative Properties and Pyxus International, which holds a controlling interest in two Canandian discs but also a domestic hemp company, are the only US companies currently listed on the NYSE, while GW Pharma, based in the US UK, trades on NASDAQ, but we expect this to change.
Earlier this year, MTech Acquisition Corp launched an IPO on NASDAQ as a blank check company and announced the current acquisition of software company MJ Freeway. The company will be renamed Akerna at the closing of the transaction. Major stock exchanges are unlikely to list companies that grow, process or sell cannabis directly, but they are likely to have other auxiliary names.
In our view, top companies to upgrade their lists include GrowGeneration and KushCo Holdings, both of which have substantial sales and sufficient equity to meet their needs. In the third quarter teleconference earlier this month, GrowGeneration CEO Darren Lampert said the company had started the process and planned to file the application within 90 days. We note that KushCo has changed the listener and increased the number of independent directors on its board, both of which we believe relate to recruitment potential. We learned that Hydrofarm also intended to sign up for a major scholarship, and we are aware of the existence of other companies that are planning to do so.
While we believe that success may depend on the legalization of hemp, CV Sciences, a supplier of CBD, has applied to NASDAQ. If successful, we would expect Charlotte's Web and Elixinol Global to follow with potentially other currently private companies.
More US companies listed on major stock exchanges will open the door to more institutional investment and will not benefit than companies that get market listing status because investors with a long-term exit strategy in the lead will probably be more confident when they invest in private assets. companies. We have already seen this year how more and more companies listed on major exchanges have had a positive impact on the interest of private investors in the cannabis sector. The cannabis industry is growing rapidly and, with this favorable trend, we expect access to capital to continue to improve.
Growers Network, a private community for commercial cannabis professionals (and our sponsor for this Sunday newsletter), has provided detailed information on some of the most interesting cannabis planting facilities in the United States. Check out episode 5 of season 1 of Canna Cribs, featuring Honeydew Farms in Humboldt County.
New Cannabis Ventures publishes selected articles as well as exclusive news. Here are some of the most interesting commercial content this week:
For real-time updates, download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and learn about industry news with like – minded people about the largest group of cannabis investors and entrepreneurs on LinkedIn.
Use the professionally managed NCV cannabis stock index series to monitor the performance of publicly traded cannabis companies in the day or over longer periods. In addition to the comprehensive Global Cannabis Stock Index, we have a family of indices to track licensed Canadian producers, as well as the American Cannabis Operator Index.
View the Cannabis Company's recipe for revenue, which ranks the top selling cannabis stocks, generating sales of more than $ 2.5 million per quarter.
Check out new announcements coming up with IPOs and follow up on Cannabis Stock issues.
Consider subscribing to 420 Investor, Alan's complete due diligence platform since 2013, for more in-depth information and market intelligence on the publicly traded cannabis sector.
Discover your place in the cannabis industry by visiting our Careers and Jobs page and discover which companies are aggressively recruiting.
Regards,
Alan & Joel
Based in Houston, Alan is relying on his experience as the founder of Online Communities 420 Investor, the first and still largest platform of due diligence focused on publicly traded stocks in the cannabis industry. Through his extensive network in the cannabis community, Alan continues to find new ways to connect the sector and facilitate sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before turning to the cannabis industry in early 2013, Alan, who started his career on Wall Street in 1986, worked as an independent research analyst after more than two decades in research and portfolio management. . A prolific writer, with over 650 articles published since 2007 on Seeking Alpha, where he has 70,000 subscribers, Alan is a frequent speaker at industry conferences and a frequent source of information for the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | E-mail
[ad_2]
Source link
